CeriBell (NASDAQ:CBLL) CEO Xingjuan Chao Sells 20,846 Shares of Stock

CeriBell, Inc. (NASDAQ:CBLL) CEO Xingjuan Chao sold 20,846 shares of the business’s stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $25.03, for a total value of $521,775.38. Following the sale, the chief executive officer owned 746,345 shares in the company, valued at approximately $18,681,015.35. This represents a 2.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Xingjuan Chao also recently made the following trade(s):

• On Wednesday, September 2nd, Xingjuan Chao sold 39,540 shares of CeriBell stock. The stock was sold at an average price of $24.61, for a total value of $973,079.40.
• On Friday, August 21st, Xingjuan Chao sold 6,068 shares of CeriBell stock. The stock was sold at an average price of $24.02, for a total transaction of $145,753.36.
• On Wednesday, August 19th, Xingjuan Chao sold 31,415 shares of CeriBell stock. The shares were sold at an average price of $25.03, for a total transaction of $786,317.45.
• On Tuesday, August 18th, Xingjuan Chao sold 2,199 shares of CeriBell stock. The shares were sold at an average price of $25.00, for a total transaction of $54,975.00.
• On Tuesday, July 7th, Xingjuan Chao sold 39,000 shares of CeriBell stock. The stock was sold at an average price of $19.90, for a total transaction of $776,100.00.

CeriBell Price Performance

Shares of CeriBell stock opened at $25.00 on Friday. The firm has a market cap of $959.50 million, a P/E ratio of -14.20 and a beta of 0.95. The firm’s 50-day simple moving average is $21.51 and its 200-day simple moving average is $19.79. CeriBell, Inc. has a twelve month low of $10.85 and a twelve month high of $25.63. The company has a debt-to-equity ratio of 0.16, a quick ratio of 8.79 and a current ratio of 9.18.

CeriBell (NASDAQ:CBLL) last posted its quarterly earnings results on Monday, August 10th. The company reported ($0.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by ($0.04). The business had revenue of $28.10 million during the quarter, compared to analyst estimates of $27.28 million. CeriBell had a negative return on equity of 44.85% and a negative net margin of 64.73%. As a group, research analysts expect that CeriBell, Inc. will post -1.96 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on CBLL shares. BTIG Research restated a “buy” rating and set a $30.00 target price on shares of CeriBell in a research report on Friday, September 11th. Canaccord Genuity Group upped their price target on CeriBell from $25.00 to $26.00 and gave the company a “buy” rating in a research report on Tuesday, August 11th. Raymond James Financial reissued a “strong-buy” rating and set a $29.00 price objective on shares of CeriBell in a report on Thursday, September 3rd. Weiss Ratings upgraded shares of CeriBell from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday. Finally, Barclays raised shares of CeriBell to a “neutral” rating in a report on Tuesday, August 18th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, CeriBell has an average rating of “Moderate Buy” and an average price target of $24.40.

Institutional Investors Weigh In On CeriBell

A number of large investors have recently bought and sold shares of the business. Strs Ohio bought a new position in CeriBell in the 1st quarter valued at $27,000. Legal & General Group Plc bought a new stake in shares of CeriBell during the second quarter worth $53,000. Caitong International Asset Management Co. Ltd increased its stake in shares of CeriBell by 8,735.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 2,739 shares of the company’s stock valued at $60,000 after buying an additional 2,708 shares in the last quarter. Larson Financial Group LLC increased its stake in shares of CeriBell by 1,403.1% in the fourth quarter. Larson Financial Group LLC now owns 2,871 shares of the company’s stock valued at $63,000 after buying an additional 2,680 shares in the last quarter. Finally, State of Wyoming bought a new position in shares of CeriBell in the first quarter valued at about $62,000.

About CeriBell

Ceribell, Inc (NASDAQ: CBLL) is a medical technology company focused on improving the detection and management of seizures and other neurological conditions in hospital settings. Its products are designed to make electroencephalography (EEG) more accessible at the point of care, particularly in emergency departments, intensive care units and other settings where conventional EEG testing may be delayed or difficult to obtain.

The company’s primary offering is the Ceribell Rapid Response EEG system, which combines a portable EEG recorder, a simplified electrode headband and software for acquiring and reviewing brain-wave data.